$736 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 104 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 44.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Buy | AMICUS THERAPEUTICS | $48,251,000 | -18.0% | 5,036,590 | +3.5% | 6.56% | +5.0% |
| AERI | Buy | AERIE PHARMACEUTIC | $40,936,000 | -14.5% | 1,133,954 | +45.9% | 5.56% | +9.5% |
| ALNY | Buy | ALNYLAM PHARMACUETCL | $36,115,000 | +7.4% | 495,341 | +29.0% | 4.91% | +37.6% |
| TDOC | Buy | TELADOC HEALTH | $31,332,000 | +16.4% | 632,075 | +102.7% | 4.26% | +49.0% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $30,862,000 | -3.0% | 2,165,767 | +3.4% | 4.20% | +24.1% |
| APLS | Buy | APELLIS PHARMACEUTIC | $28,597,000 | -21.1% | 2,168,115 | +6.4% | 3.89% | +1.0% |
| GILD | Buy | GILEAD SCIENCES INC | $26,577,000 | +29.3% | 424,890 | +59.6% | 3.61% | +65.6% |
| CELG | Buy | CELGENE CORP | $25,444,000 | +1.2% | 397,012 | +41.3% | 3.46% | +29.6% |
| COLL | Sell | COLLEGIUM PHARMACEUT | $19,865,000 | -32.3% | 1,156,934 | -41.8% | 2.70% | -13.3% |
| PFE | Sell | PFIZER INC | $18,565,000 | -6.4% | 425,326 | -5.5% | 2.52% | +19.9% |
| IMMU | Buy | IMMUNOMEDICS INC | $18,570,000 | +15.6% | 1,301,305 | +68.7% | 2.52% | +47.9% |
| NVS | Sell | NOVARTIS AGadr | $18,316,000 | -6.4% | 213,446 | -6.0% | 2.49% | +19.8% |
| LJPC | Buy | LA JOLLA PHARMACLS | $16,589,000 | -50.0% | 1,759,171 | +6.7% | 2.26% | -36.0% |
| PTLA | Buy | PORTOLA PHARMACEUTIC | $16,077,000 | -18.9% | 823,607 | +10.6% | 2.18% | +3.8% |
| RARX | Buy | RA PHARMACEUTICALS | $14,553,000 | +130.7% | 799,612 | +129.3% | 1.98% | +195.2% |
| WMGI | Buy | WRIGHT MED GROUP N V | $14,548,000 | +12.0% | 534,472 | +19.4% | 1.98% | +43.4% |
| HRC | Buy | HILL-ROM HLDS INC | $14,186,000 | +12.7% | 160,199 | +20.1% | 1.93% | +44.3% |
| BMY | Buy | BRISTOL MYERS SQUIBB | $13,369,000 | -10.5% | 257,197 | +6.9% | 1.82% | +14.6% |
| CI | New | CIGNA CORP | $12,747,000 | – | 67,119 | +100.0% | 1.73% | – |
| LLY | Buy | ELI LILLY & CO | $12,054,000 | +101.4% | 104,166 | +86.8% | 1.64% | +158.1% |
| EVH | Buy | EVOLENT HEALTH INC | $11,749,000 | -26.7% | 588,902 | +4.4% | 1.60% | -6.1% |
| GBT | Buy | GLOBAL BLOOD THERA | $11,598,000 | +28.2% | 282,541 | +18.7% | 1.58% | +64.3% |
| UNH | Sell | UNITEDHEALTH GRP INC | $10,913,000 | -29.0% | 43,806 | -24.2% | 1.48% | -9.2% |
| ATRC | Buy | ATRICURE INC | $10,885,000 | +23.9% | 355,728 | +41.8% | 1.48% | +58.6% |
| MDT | Sell | MEDTRONIC PLC | $10,683,000 | -17.0% | 117,451 | -10.2% | 1.45% | +6.2% |
| VCRA | Buy | VOCERA COMMUNICATI | $10,405,000 | +30.9% | 264,421 | +21.7% | 1.41% | +67.5% |
| ADMS | Buy | ADAMAS PHARMACEUTI | $9,684,000 | -46.5% | 1,133,924 | +25.5% | 1.32% | -31.5% |
| XLRN | Sell | ACCELERON PHARMA | $9,221,000 | -46.1% | 211,726 | -29.1% | 1.25% | -31.0% |
| BSX | Sell | BOSTON SCIENTIFIC | $8,548,000 | -11.7% | 241,876 | -3.8% | 1.16% | +13.1% |
| RCM | Buy | R1 RCM INC | $8,510,000 | +13.8% | 1,070,498 | +45.5% | 1.16% | +45.7% |
| EXAS | Sell | EXACT SCIENCES CORP | $8,465,000 | -58.9% | 134,150 | -48.6% | 1.15% | -47.4% |
| Sell | INTEC PHARMA LTD JER | $8,341,000 | +25.4% | 1,106,175 | -6.0% | 1.13% | +60.6% | |
| PTCT | Buy | PTC THERAPEUTICS I | $8,015,000 | -16.5% | 233,536 | +14.3% | 1.09% | +7.0% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $7,802,000 | -56.4% | 91,621 | -50.4% | 1.06% | -44.2% |
| TNDM | Buy | TANDEM DIABETES CARE | $7,710,000 | +318.8% | 203,067 | +372.6% | 1.05% | +437.4% |
| PODD | INSULET CORP | $7,643,000 | -25.1% | 96,360 | 0.0% | 1.04% | -4.2% | |
| VRAY | Buy | VIEWRAY INC | $7,287,000 | -26.3% | 1,200,564 | +13.7% | 0.99% | -5.6% |
| ABMD | Sell | ABIOMED INC | $7,290,000 | -43.5% | 22,427 | -21.8% | 0.99% | -27.6% |
| OBSV | OBSEVA SA | $7,149,000 | -29.8% | 564,692 | 0.0% | 0.97% | -10.1% | |
| ABT | Sell | ABBOTT LABS | $7,059,000 | -12.0% | 97,598 | -10.8% | 0.96% | +12.7% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES | $6,767,000 | -50.6% | 97,400 | -32.7% | 0.92% | -36.7% |
| SVRA | Buy | SAVARA INC | $6,408,000 | -28.8% | 846,500 | +5.0% | 0.87% | -8.9% |
| SGEN | Buy | SEATTLE GENETICS INC | $6,348,000 | +526.7% | 112,029 | +753.2% | 0.86% | +699.1% |
| VRTX | Sell | VERTEX PHARMACEUTICL | $6,002,000 | -59.5% | 36,217 | -52.9% | 0.82% | -48.1% |
| ALBO | Buy | ALBIREO PHARMA INC | $5,641,000 | -9.7% | 229,978 | +21.3% | 0.77% | +15.7% |
| BIIB | Buy | BIOGEN INC | $5,507,000 | +838.2% | 18,301 | +1001.1% | 0.75% | +1108.1% |
| UMRX | Buy | UNUM THERAPEUTICS | $5,501,000 | -49.0% | 1,250,145 | +19.4% | 0.75% | -34.7% |
| EVLO | EVELO BIOSCIENCES | $5,297,000 | +6.8% | 407,171 | 0.0% | 0.72% | +36.9% | |
| PTI | New | PROTEOSTASIS THERA | $5,125,000 | – | 1,581,728 | +100.0% | 0.70% | – |
| WCG | Buy | WELLCARE HEALTH PLAN | $4,586,000 | +660.5% | 19,425 | +932.7% | 0.62% | +873.4% |
| MGTX | MEIRAGTX HLDINGS PLC | $3,932,000 | -29.1% | 407,906 | 0.0% | 0.53% | -9.3% | |
| ASMB | New | ASSEMBLY BIOSCIENCES | $3,560,000 | – | 157,400 | +100.0% | 0.48% | – |
| SAGE | SAGE THERAPEUTICS | $3,554,000 | -32.2% | 37,100 | 0.0% | 0.48% | -13.1% | |
| MDGL | Buy | MADRIGAL PHARMACEUTI | $3,211,000 | -42.1% | 28,487 | +10.0% | 0.44% | -25.9% |
| CSII | New | CARDIOVASCULAR SYS | $2,874,000 | – | 100,862 | +100.0% | 0.39% | – |
| NITE | Sell | NIGHTSTAR THERAPEUadr | $2,692,000 | -44.7% | 233,711 | -1.9% | 0.37% | -29.2% |
| SBPH | Sell | SPRING BK PHARMACE | $2,615,000 | -25.6% | 251,656 | -13.7% | 0.36% | -4.8% |
| JNJ | Sell | JOHNSON & JOHNSON | $2,297,000 | -88.1% | 17,799 | -87.2% | 0.31% | -84.7% |
| BGNE | Buy | BEIGENE LIMITEDsp adr | $2,094,000 | +22.5% | 14,927 | +50.4% | 0.28% | +56.6% |
| MTEM | MOLECULAR TEMPLATES | $1,414,000 | -25.1% | 350,000 | 0.0% | 0.19% | -4.0% | |
| ALDR | Sell | ALDER BIOPHARMACEU | $1,315,000 | -87.0% | 128,300 | -79.0% | 0.18% | -83.4% |
| TMO | THERMO FISHER SCI | $1,018,000 | -8.3% | 4,549 | 0.0% | 0.14% | +16.9% | |
| ANTM | Sell | ANTHEM INC | $883,000 | -5.0% | 3,361 | -0.9% | 0.12% | +21.2% |
| HCM | HUTCHISON CHINA MEsp adr | $730,000 | -28.3% | 31,628 | 0.0% | 0.10% | -8.3% | |
| RDY | Sell | DR REDDYS LABS LTDadr | $682,000 | -8.7% | 18,097 | -16.2% | 0.09% | +17.7% |
| BDX | BECTON DICKINSON | $679,000 | -13.7% | 3,015 | 0.0% | 0.09% | +9.5% | |
| HCA | Buy | HCA HEALTHCARE | $662,000 | -9.9% | 5,316 | +0.6% | 0.09% | +15.4% |
| IMGN | Buy | IMMUNOGEN INC | $650,000 | +226.6% | 135,313 | +543.9% | 0.09% | +319.0% |
| HUM | Buy | HUMANA INC | $526,000 | +63.9% | 1,836 | +93.5% | 0.07% | +111.8% |
| RARE | ULTRAGENYX PHARMAC | $393,000 | -43.1% | 9,047 | 0.0% | 0.05% | -27.4% | |
| STML | Buy | STEMLINE THERAPEUT | $369,000 | +19.8% | 38,838 | +109.5% | 0.05% | +51.5% |
| SRRA | SIERRA ONCOLOGY INC | $343,000 | 0.0% | 201,660 | 0.0% | 0.05% | +30.6% | |
| KALV | KALVISTA PHARMACEUTI | $347,000 | -10.6% | 17,551 | 0.0% | 0.05% | +14.6% | |
| HMSY | Buy | HMS HOLDINGS CORP | $349,000 | -13.6% | 12,397 | +0.7% | 0.05% | +9.3% |
| UHS | Buy | UNIVERSAL HEALTH SVCcl b | $338,000 | -5.8% | 2,896 | +3.0% | 0.05% | +21.1% |
| SYK | STRYKER CORP | $324,000 | -11.7% | 2,066 | 0.0% | 0.04% | +12.8% | |
| CERS | CERUS CORP | $307,000 | -29.7% | 60,576 | 0.0% | 0.04% | -8.7% | |
| DERM | DERMIRA INC | $301,000 | -34.1% | 41,902 | 0.0% | 0.04% | -16.3% | |
| ZLAB | Sell | ZAI LAB LTDadr | $292,000 | -66.7% | 12,589 | -72.0% | 0.04% | -57.0% |
| CHRS | COHERUS BIOSCIENCES | $253,000 | -45.2% | 27,987 | 0.0% | 0.03% | -30.6% | |
| CNC | Sell | CENTENE CORP DEL | $240,000 | -20.8% | 2,080 | -0.5% | 0.03% | +3.1% |
| KANG | IKANG HEALTHCARE Gsp adr | $235,000 | +13.0% | 11,513 | 0.0% | 0.03% | +45.5% | |
| RVNC | REVANCE THERAPEUTI | $226,000 | -19.0% | 11,234 | 0.0% | 0.03% | +3.3% | |
| BPMC | BLUEPRINT MEDICINES | $226,000 | -30.9% | 4,184 | 0.0% | 0.03% | -11.4% | |
| ZBH | ZIMMER BIOMET HLDS | $218,000 | -21.0% | 2,099 | 0.0% | 0.03% | +3.4% | |
| CCXI | CHEMOCENTRYX INC | $194,000 | -13.8% | 17,811 | 0.0% | 0.03% | +8.3% | |
| KURA | KURA ONCOLOGY INC | $166,000 | -19.8% | 11,800 | 0.0% | 0.02% | +4.5% | |
| ACRX | ACELRX PHARMACEUTI | $170,000 | -40.1% | 73,778 | 0.0% | 0.02% | -23.3% | |
| CTMX | CYTOMX THERAPEUTIC | $152,000 | -18.3% | 10,058 | 0.0% | 0.02% | +5.0% | |
| ATRS | ANTARES PHARMA INC | $129,000 | -18.9% | 47,280 | 0.0% | 0.02% | +5.9% | |
| MEIP | MEI PHARMA INC | $118,000 | -38.5% | 44,539 | 0.0% | 0.02% | -20.0% | |
| QTNT | QUOTIENT LTD | $108,000 | -18.8% | 17,649 | 0.0% | 0.02% | +7.1% | |
| AGLE | AEGLEA BIOTHERAPEU | $97,000 | -21.8% | 12,954 | 0.0% | 0.01% | 0.0% | |
| CYTK | CYTOKINETICS INC | $98,000 | -35.9% | 15,582 | 0.0% | 0.01% | -18.8% | |
| BLRX | BIOLINERX LTDsp adr | $87,000 | -59.0% | 198,297 | 0.0% | 0.01% | -47.8% | |
| ABEO | ABEONA THERAPEUTICS | $91,000 | -43.8% | 12,681 | 0.0% | 0.01% | -29.4% | |
| PTGX | New | PROTAGONIST THERAP | $77,000 | – | 11,400 | +100.0% | 0.01% | – |
| NABRIVA THERAPEUTICS | $56,000 | -45.6% | 38,255 | 0.0% | 0.01% | -27.3% | ||
| CDTX | CIDARA THERAPEUTICS | $60,000 | -46.4% | 25,447 | 0.0% | 0.01% | -33.3% | |
| MRNS | MARINUS PHARMACUTCLS | $48,000 | -71.4% | 16,800 | 0.0% | 0.01% | -61.1% | |
| TTPH | TETRAPHASE PHARMAC | $45,000 | -59.1% | 39,821 | 0.0% | 0.01% | -50.0% | |
| CRVS | CORVUS PHARMACEUTI | $46,000 | -57.4% | 12,594 | 0.0% | 0.01% | -45.5% | |
| CLSD | CLEARSIDE BIOMEDIC | $28,000 | -82.5% | 25,959 | 0.0% | 0.00% | -76.5% | |
| PLX | PROTALIX BIOTHERA | $31,000 | -56.9% | 99,667 | 0.0% | 0.00% | -50.0% | |
| AGRX | Exit | AGILE THERAPEUTICS | $0 | – | -45,000 | -100.0% | -0.00% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES | $0 | – | -32,936 | -100.0% | -0.00% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS | $0 | – | -12,000 | -100.0% | -0.00% | – |
| SLNO | Exit | SOLENO THERAPEUTICS | $0 | – | -21,587 | -100.0% | -0.01% | – |
| CNAT | Exit | CONATUS PHARMACEUTICALS | $0 | – | -10,364 | -100.0% | -0.01% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALSsp adr | $0 | – | -15,218 | -100.0% | -0.01% | – |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -32,241 | -100.0% | -0.01% | – |
| Exit | PROTAGONIST THERAPEUTICS | $0 | – | -11,400 | -100.0% | -0.01% | – | |
| PGNX | Exit | PROGENICS PHARMACEUTICALS | $0 | – | -18,002 | -100.0% | -0.01% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS | $0 | – | -12,739 | -100.0% | -0.01% | – |
| AVEO | Exit | AVEO PHARMACUTICALS | $0 | – | -36,000 | -100.0% | -0.01% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -18,921 | -100.0% | -0.02% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS | $0 | – | -12,957 | -100.0% | -0.02% | – |
| BDSI | Exit | BIODELIVERY SCIENCES | $0 | – | -54,434 | -100.0% | -0.02% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS | $0 | – | -15,367 | -100.0% | -0.02% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES | $0 | – | -12,609 | -100.0% | -0.02% | – |
| AMRX | Exit | AMNEAL PHARMACEUTICALS | $0 | – | -9,040 | -100.0% | -0.02% | – |
| GTHX | Exit | G1 THERAPEUTICS | $0 | – | -3,857 | -100.0% | -0.02% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS | $0 | – | -13,920 | -100.0% | -0.02% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -2,975 | -100.0% | -0.02% | – |
| TEVA | Exit | TEVA PHARMACEUTICALsp adr | $0 | – | -10,120 | -100.0% | -0.02% | – |
| AET | Exit | AETNA INC | $0 | – | -1,143 | -100.0% | -0.02% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -13,141 | -100.0% | -0.02% | – |
| SHPG | Exit | SHIRE PLCsp adr | $0 | – | -1,300 | -100.0% | -0.02% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE | $0 | – | -3,418 | -100.0% | -0.03% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -3,298 | -100.0% | -0.03% | – |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -4,841 | -100.0% | -0.03% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -3,533 | -100.0% | -0.03% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -4,051 | -100.0% | -0.03% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA | $0 | – | -7,945 | -100.0% | -0.03% | – |
| STE | Exit | STERIS PLC | $0 | – | -2,406 | -100.0% | -0.03% | – |
| ICLR | Exit | ICON PLC | $0 | – | -1,780 | -100.0% | -0.03% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS | $0 | – | -15,400 | -100.0% | -0.03% | – |
| AZN | Exit | ASTRAZENECAsp adr | $0 | – | -7,100 | -100.0% | -0.03% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsp adr | $0 | – | -7,300 | -100.0% | -0.03% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -10,226 | -100.0% | -0.03% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -9,614 | -100.0% | -0.03% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -10,036 | -100.0% | -0.03% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS | $0 | – | -98,609 | -100.0% | -0.03% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS | $0 | – | -7,208 | -100.0% | -0.04% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -6,171 | -100.0% | -0.04% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -626 | -100.0% | -0.04% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICAKS | $0 | – | -13,458 | -100.0% | -0.04% | – |
| AKCA | Exit | AKCEA THERAPEUTICS | $0 | – | -10,356 | -100.0% | -0.04% | – |
| DHR | Exit | DANAHER CORP | $0 | – | -3,556 | -100.0% | -0.04% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -2,957 | -100.0% | -0.05% | – |
| HRTX | Exit | HERON THERAPEUTICS | $0 | – | -15,243 | -100.0% | -0.05% | – |
| ATHN | Exit | ATHENAHEALTH INC | $0 | – | -3,724 | -100.0% | -0.05% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -3,842 | -100.0% | -0.05% | – |
| MYL | Exit | MYLAN N V | $0 | – | -14,329 | -100.0% | -0.06% | – |
| LOXO | Exit | LOXO ONCOLOGY INC | $0 | – | -3,195 | -100.0% | -0.06% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -1,370 | -100.0% | -0.06% | – |
| Exit | EDWARDS LIFESCIENCES | $0 | – | -3,705 | -100.0% | -0.07% | – | |
| INCY | Exit | INCYTE CORPORATION | $0 | – | -11,113 | -100.0% | -0.08% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES | $0 | – | -6,803 | -100.0% | -0.09% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -20,585 | -100.0% | -0.09% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -57,144 | -100.0% | -0.10% | – |
| CMTA | Exit | CLEMENTIA PHARMACEUTICALS | $0 | – | -123,405 | -100.0% | -0.15% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -7,771 | -100.0% | -0.16% | – |
| FIXX | Exit | HOMOLOGY MEDICINES | $0 | – | -143,487 | -100.0% | -0.35% | – |
| ESPR | Exit | ESPERION THERAPEUTICS | $0 | – | -96,100 | -100.0% | -0.45% | – |
| AGIO | Exit | AGIOS PHARMACEUTICS | $0 | – | -56,207 | -100.0% | -0.46% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS | $0 | – | -27,000 | -100.0% | -0.46% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -35,102 | -100.0% | -0.46% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -82,263 | -100.0% | -0.53% | – |
| CI | Exit | CIGNA CORP | $0 | – | -46,530 | -100.0% | -1.03% | – |
| ALXN | Exit | ALEXION PHARM INC | $0 | – | -88,399 | -100.0% | -1.30% | – |
| CLVS | Exit | CLOVIS ONCOLOGY | $0 | – | -443,397 | -100.0% | -1.38% | – |
| KTWO | Exit | K2M GROUP HOLDINGS | $0 | – | -906,741 | -100.0% | -2.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.